Showing results (21-30 of 70) with videos related to
Sort By:
Pageof 7
Antibiotics (Basel, Switzerland)|October 28, 2025
URO-RESIST: A Real-World Retrospective Study on Multidrug-Resistant Sepsis with Urinary Tract Infection, Clinical Predictors, Inflammatory Biomarkers, and Patient OutcomesLivia Moffa, Claudio Tana, Claudio Ucciferri, et al.Multidisciplinary Respiratory Medicine|December 1, 2025
An Italian multidisciplinary Delphi Consensus on new insights about the clinical relevance of PidotimodGianluigi Marseglia, Matteo Gelardi, Paola Marchisio, et al.Pathogens (Basel, Switzerland)|October 27, 2022
Molnupiravir as an Early Treatment for COVID-19: A Real Life StudyMichela Pontolillo, Claudio Ucciferri, Paola Borrelli, et al.Infectious Disease Reports|March 22, 2022
Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center ExperienceClaudio Ucciferri, Antonio Auricchio, Carmine Cutone, et al.Nutrients|October 2, 2015
Effect of Probiotic Supplement on Cytokine Levels in HIV-Infected Individuals: A Preliminary StudyKatia Falasca, Jacopo Vecchiet, Claudio Ucciferri, et al.Journal of Medical Virology|October 16, 2015
High prevalence of human papillomavirus type 58 in HIV infected men who have sex with men: A preliminary report in Central ItalyMichela Lucia Sammarco, Claudio Ucciferri, Manuela Tamburro, et al.Journal of Medical Virology|September 15, 2017
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with menClaudio Ucciferri, Manuela Tamburro, Katia Falasca, et al.Journal of Medical Virology|March 20, 2013
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapyClaudio Ucciferri, Katia Falasca, Francesca Vignale, et al.Hepato-Gastroenterology|February 13, 2008
High dose of erythropoietin in management of interferon/ribavirin induced anemiaClaudio Ucciferri, Katia Falasca, Paola Mancino, et al.Microorganisms|November 11, 2022
New Therapeutic Options in Mild Moderate COVID-19 OutpatientsClaudio Ucciferri, Alessandro Di Gasbarro, Paola Borrelli, et al.Pageof 7